Roche announces positive results for Actemra in phase III study

Swiss drugmaker Roche said on Sunday its rheumatoid arthritis medication Actemra for giant cell arteritis showed to be superior to steroids alone in maintaining steroid-free remission in a Phase III study. Results from the study showed that 56 percent of patients treated with Actemra – known as RoActemra in European markets -achieved steroid-free disease remission […]

J&J arthritis drug goes up against Humira, with mixed results

(Reuters) – Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc's top-selling Humira in a large trial. By one measure, patients with moderate to severe disease who took sirukumab showed significantly greater improvement in the Phase III study than those taking Humira, J&J said on Saturday. In […]